Not applicableWithdrawnNCT03537521
What this trial is testing
Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots
Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien